Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance

HUANG Jie; WANG Zhen

doi:10.12019/j.issn.1671-5144.2017.04.005

HUANG Jie, WANG Zhen. Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance[J]. Journal of Evidence-Based Medicine, 2017, 17(4): 211-212. DOI: 10.12019/j.issn.1671-5144.2017.04.005

Citation:

HUANG Jie, WANG Zhen. Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance[J]. Journal of Evidence-Based Medicine, 2017, 17(4): 211-212. DOI: 10.12019/j.issn.1671-5144.2017.04.005

Citation:

HUANG Jie, WANG Zhen. Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance[J]. Journal of Evidence-Based Medicine, 2017, 17(4): 211-212. DOI: 10.12019/j.issn.1671-5144.2017.04.005

Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance

Graphical Abstract

Abstract

FullText(HTML)

References (5)

Lung Adenocarcinoma Harboring EGFR T790M and in Trans C797S Responds to Combination Therapy of First and Third Generation EGFR-TKIs and Shifts Allelic Configuration at Resistance

Catalog

Export File

Citation

Format

Content